lifestyle.trondstidkontroll.com

Author: Virax BioLabs Group Limited

Virax Biolabs’ CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

April 14, 2026
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

March 31, 2026
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

December 5, 2025
Virax Biolabs Group Limited Announces $5 Million Private Placement

December 4, 2025
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes

November 5, 2025